Delivery Order SPE2DB20D7066-SPE2DB24FC2FB
- Not listed
- This federal contract award, valued at $13,660.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 9, 2024 and utilizes a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,970.57 and is a firm fixed-price delivery order with a completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $17,483.65, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a Firm Fixed Price delivery order contract with a completion date of January 8, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,404,006 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,720.56 and is a Firm Fixed Price Delivery Order, with a period of performance through November 13, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $4,765.13. It is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of July 17, 2025. This award is part of Amerisourcebergen Drug Corp's...
- This federal contract award, valued at $2,321.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,063 units of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price delivery order. It is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,002.24 firm-fixed-price delivery order is for the supply of ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,703.06 firm fixed-price delivery order is for the supply of 4,564,997,915 units of the medication Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has a completion date of June 26, 2024 and was awarded on June 25, 2024. This delivery order is part of a larger $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,952.03 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $1,822.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,269,056 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB24FC2FBDelivery Order
This federal contract award, with ID SPE2DB20D7066|SPE2DB24FC2FB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $23,519.07 and is a firm fixed-price delivery order, with a completion date of June 5, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 6/4/24 |